CH526566A - Verfahren zur Herstellung von 5-Pyridyl-2-imidazolonen - Google Patents

Verfahren zur Herstellung von 5-Pyridyl-2-imidazolonen

Info

Publication number
CH526566A
CH526566A CH277770A CH277770A CH526566A CH 526566 A CH526566 A CH 526566A CH 277770 A CH277770 A CH 277770A CH 277770 A CH277770 A CH 277770A CH 526566 A CH526566 A CH 526566A
Authority
CH
Switzerland
Prior art keywords
imidazolones
pyridyl
preparation
Prior art date
Application number
CH277770A
Other languages
German (de)
English (en)
Inventor
Gruenfeld Norbert
Charles Jr Pesterfield Enos
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of CH526566A publication Critical patent/CH526566A/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CH277770A 1969-02-28 1970-02-26 Verfahren zur Herstellung von 5-Pyridyl-2-imidazolonen CH526566A (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80345869A 1969-02-28 1969-02-28
US814270A 1970-01-19 1970-01-19

Publications (1)

Publication Number Publication Date
CH526566A true CH526566A (de) 1972-08-15

Family

ID=26677851

Family Applications (1)

Application Number Title Priority Date Filing Date
CH277770A CH526566A (de) 1969-02-28 1970-02-26 Verfahren zur Herstellung von 5-Pyridyl-2-imidazolonen

Country Status (8)

Country Link
US (2) US3538104A (enExample)
AT (1) AT290529B (enExample)
BE (1) BE746656A (enExample)
CH (1) CH526566A (enExample)
DE (1) DE2009408A1 (enExample)
FR (1) FR2034575B1 (enExample)
GB (1) GB1305273A (enExample)
NL (1) NL7002463A (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH561202A5 (enExample) * 1971-05-10 1975-04-30 Ciba Geigy Ag
US4405628A (en) * 1981-03-05 1983-09-20 Merrell Dow Pharmaceuticals Inc. 4-Pyridylimidazolones and method of use
US4532250A (en) * 1983-11-23 1985-07-30 American Hospital Supply Corporation 5-Heteroarylimidazol-2-ones having cardiotonic activity
US4728661A (en) * 1985-11-13 1988-03-01 Merrell Dow Pharmaceuticals Inc. Cardiotonic phenyl oxazolones
US4698353A (en) * 1985-11-13 1987-10-06 Merrell Dow Pharmaceuticals Inc. Cardiotonic heterocyclic oxazolones
US4670450A (en) * 1985-11-13 1987-06-02 Merrell Dow Pharmaceuticals Inc. Cardiotonic thiazolones
US4911753A (en) * 1987-01-21 1990-03-27 American Cyanamid Company Herbicidal 2-(2-imidazolin-2-yl)fluoroalkoxy-, alkenyloxy-, and alkynyloxypyridines and quinolines
CA2450073C (en) 2001-07-25 2017-08-29 Biomarin Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
AU2004201666C1 (en) * 2001-10-22 2006-10-12 Tanabe Seiyaku Co., Ltd. 4-Imidazolin-2-one compounds
US7473695B2 (en) * 2001-10-22 2009-01-06 Mitsubishi Tanabe Pharma Corporation 4-imidazolin-2-one compounds
MXPA04003729A (es) 2001-10-22 2004-07-23 Tanabe Seiyaku Co Compuestos de 4-imidazolin-2-ona.
ES2362877T3 (es) * 2003-04-21 2011-07-14 Mitsubishi Tanabe Pharma Corporation Compuestos de imidazolin-2-ona.
EP2671508B1 (en) 2005-04-28 2020-09-16 Proteus Digital Health, Inc. Pharma-informatics system
JP2010503710A (ja) 2006-09-18 2010-02-04 ラプトール ファーマシューティカル インコーポレイテッド 受容体関連タンパク質(rap)結合体の投与による肝障害の処置
KR20180114970A (ko) 2009-05-06 2018-10-19 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Also Published As

Publication number Publication date
AT290529B (de) 1971-06-11
US3538104A (en) 1970-11-03
NL7002463A (enExample) 1970-09-01
BE746656A (fr) 1970-08-27
US3678169A (en) 1972-07-18
DE2009408A1 (de) 1970-09-17
FR2034575A1 (enExample) 1970-12-11
FR2034575B1 (enExample) 1973-07-13
GB1305273A (enExample) 1973-01-31

Similar Documents

Publication Publication Date Title
AT298508B (de) Verfahren zur Herstellung von Mercaptoalkylalkoxysilanen
AT302277B (de) Verfahren zur Herstellung von Chinondiiminen
CH508604A (de) Verfahren zur Herstellung von Ureidophenylguanidinen
CH533103A (de) Verfahren zur Herstellung von 4-Acyloxy-azetidin-2-onen
AT304774B (de) Verfahren zur Herstellung von 16β-Methyl-9α-fluor-steroiden
CH525881A (de) Verfahren zur Herstellung von 4-Alkylprolinen
CH505041A (de) Verfahren zur Herstellung von Cycloalkenonen
CH531480A (de) Verfahren zur Herstellung von Aminoadamantanen
AT296961B (de) Verfahren zur Herstellung von Alkyldihydroxybenzolen
AT319485B (de) Verfahren zur Herstellung von 19-Norsteroiden
CH511225A (de) Verfahren zur Herstellung von Amidophenylthioharnstoffen
AT308086B (de) Verfahren zur Herstellung von 1-Alkoxyanthrachinonen
CH529108A (de) Verfahren zur Herstellung von y-Cyanbutyraldiminen
AT296297B (de) Verfahren zur Herstellung von N-Tritylimidazolen und -triazolen
CH530408A (de) Verfahren zur Herstellung von Chinolylpiperazinen
AT296298B (de) Verfahren zur Herstellung von N-Tritylimidazolen und -triazolen
AT299905B (de) Verfahren zur Herstellung von β-Acetoxypivalinaldehyd
CH534673A (de) Verfahren zur Herstellung von 9a-Fluor-16-fluor-methylenprednisolon-21-önanthat
CH530358A (de) Verfahren zur Herstellung von 2-Methyl-4-halogen-but-2-en-1-alen
CH534135A (de) Verfahren zur Herstellung von O-Carbamoylamidoximen
CH532070A (de) Verfahren zur Herstellung von 3-Methyl-isoxazol
AT299252B (de) Verfahren zur Herstellung von Organo-H-chlorsilanen
AT294833B (de) Verfahren zur Herstellung von N-Tritylimidazolen und -triazolen
AT299907B (de) Verfahren zur Herstellung von Trimethyl-2-cyclohexen-1-onen
AT294834B (de) Verfahren zur Herstellung von 4-Alkoxy-piperidinen

Legal Events

Date Code Title Description
PL Patent ceased